Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mishaela R Rubin

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Bone|November 23, 2018
Skeletal Manifestations of HypoparathyroidismMishaela R Rubin
Endocrinology and Metabolism Clinics of North America|November 5, 2018
Skeletal Manifestations of HypoparathyroidismMishaela R Rubin
Journal of the Endocrine Society|June 16, 2023
The Role of the Patient Partnership in Designing Research on Neuropsychiatric Issues in HypoparathyroidismMishaela R Rubin
Annals of the New York Academy of Sciences|September 20, 2017
Skeletal fragility in diabetesMishaela R Rubin
Endocrine|February 26, 2013
Type 2 diabetes and fractures: more information is neededMishaela R Rubin
F1000Research|August 9, 2020
Recent advances in understanding and managing hypoparathyroidismMishaela R Rubin
Current Osteoporosis Reports|March 6, 2015
Bone cells and bone turnover in diabetes mellitusMishaela R Rubin
Bone|October 6, 2023
Role of advanced glycation endproducts in bone fragility in type 1 diabetesMishaela R Rubin, Ruban Dhaliwal
Current Osteoporosis Reports|March 11, 2006
Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosisJohn P Bilezikian, Mishaela R Rubin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Vascular calcification and osteoporosis--the nature of the nexusMishaela R Rubin, Shonni J Silverberg
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Bone|November 23, 2018
Skeletal Manifestations of HypoparathyroidismMishaela R Rubin
Endocrinology and Metabolism Clinics of North America|November 5, 2018
Skeletal Manifestations of HypoparathyroidismMishaela R Rubin
Journal of the Endocrine Society|June 16, 2023
The Role of the Patient Partnership in Designing Research on Neuropsychiatric Issues in HypoparathyroidismMishaela R Rubin
Annals of the New York Academy of Sciences|September 20, 2017
Skeletal fragility in diabetesMishaela R Rubin
Endocrine|February 26, 2013
Type 2 diabetes and fractures: more information is neededMishaela R Rubin
F1000Research|August 9, 2020
Recent advances in understanding and managing hypoparathyroidismMishaela R Rubin
Current Osteoporosis Reports|March 6, 2015
Bone cells and bone turnover in diabetes mellitusMishaela R Rubin
Bone|October 6, 2023
Role of advanced glycation endproducts in bone fragility in type 1 diabetesMishaela R Rubin, Ruban Dhaliwal
Current Osteoporosis Reports|March 11, 2006
Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosisJohn P Bilezikian, Mishaela R Rubin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Vascular calcification and osteoporosis--the nature of the nexusMishaela R Rubin, Shonni J Silverberg
Pageof 10